NCT05539053View on ClinicalTrials.gov

Efficacy of NAC for the Prevention and Relief of PIPN in Women With Ovarian, Tubal, and Peritoneal Cancer

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

November 30, 2023

Study Completion Date

December 30, 2023

Conditions
Chemotherapy-induced Peripheral Neuropathy
Interventions
DRUG

N Acetylcysteine A

paclitaxel + N-Acetylcysteine orally short course

DRUG

N Acetylcysteine B

paclitaxel +N Acetylcysteine orally long course

Trial Locations (1)

10400

Rajavithi Hospital, Bangkok

All Listed Sponsors
lead

Department of Medical Services Ministry of Public Health of Thailand

OTHER_GOV